Jing-Hang Xu
Overview
Explore the profile of Jing-Hang Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Wang S, Zhang D, Yu Y, Si C, Zeng Z, et al.
World J Clin Cases
. 2022 Oct;
10(28):10085-10096.
PMID: 36246814
Background: Entecavir (ETV) is a potent and selective nucleotide analog with significant activity against hepatitis B virus (HBV). ETV maleate is a derivative compound of ETV and was reported to...
2.
Lo E, Felicianna , Xu J, Zhan Q, Zeng Z, El-Nezami H
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740464
Chronic liver diseases pose a substantial health burden worldwide, with approximately two million deaths each year. Branched-chain amino acids (BCAAs)-valine, leucine, and isoleucine-are a group of essential amino acids that...
3.
Xu J, Fan Y, Yu Y, Si C, Zeng Z, Xu Z, et al.
J Viral Hepat
. 2022 Jun;
29(10):862-867.
PMID: 35737855
This study aimed to evaluate the efficacy and safety of entecavir(ETV) versus ETV maleate in Chinese patients with chronic hepatitis B(CHB). This was a randomized, double-blind, double-dummy, controlled, multicentre study....
4.
Zhan Q, Xu J, Yu Y, Lo Kk E, El-Nezami H, Zeng Z
World J Gastroenterol
. 2021 Jul;
27(25):3790-3801.
PMID: 34321844
Hepatitis B virus (HBV) infection is a public health threat that affects 257 million people worldwide and can progress to liver cirrhosis, liver failure, and hepatocellular carcinoma. The HBV antigen-...
5.
Chen X, Fan Y, Si C, Yu Y, Shang J, Yu Z, et al.
World J Clin Cases
. 2021 Jul;
9(18):4690-4699.
PMID: 34222435
Background: Tenofovir disoproxil fumarate (TDF) is a prodrug of a nucleotide analogue. As an antiviral drug, TDF has been proposed in the first-line treatment of chronic hepatitis B (CHB). Qingzhong,...
6.
Xu X, Ding H, Li W, Xu J, Han Y, Jia J, et al.
World J Gastroenterol
. 2020 Dec;
26(45):7088-7103.
PMID: 33362370
Based on reviews of the literature and experts' consensus, the Chinese Society of Hepatology developed guidelines for the diagnosis and treatment of liver cirrhosis, in order to improve clinical practice....
7.
Xu J, Yu Y, Xu X
Chin Med J (Engl)
. 2020 Sep;
133(22):2647-2649.
PMID: 32925282
No abstract available.
8.
Liang R, Xu J, Si C, Wang S, Shang J, Yu Z, et al.
Medicine (Baltimore)
. 2019 Aug;
98(33):e16778.
PMID: 31415381
Background: Tenofovir disoproxil fumarate (TDF) has been widely recommended as a first-line antiviral agent to treat chronic hepatitis B (CHB). Qingzhong and Viread, formulations of TDF commercialized by Jiangsu Chia-tai...
9.
Xu J, He S, Wu S, Huang J, Zhou W, Chen X
Chemosphere
. 2016 Jan;
147:203-9.
PMID: 26766357
Organic Carbon added to low ratio of carbon to nitrogen (C/N ratio) wastewater to enhance heterotrophic denitrification performance might lead to higher operating costs and secondary pollution. In this study,...
10.
Li N, Xu J, Yu M, Wang S, Si C, Yu Y
World J Gastroenterol
. 2015 Nov;
21(43):12421-9.
PMID: 26604649
Aim: To investigate whether long-term low-level hepatitis B virus (HBV) DNA influences dynamic changes of the FIB-4 index in chronic hepatitis B (CHB) patients receiving entecavir (ETV) therapy with partial...